SEC Form 4 · accession 0001161697-15-000370
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip H Coelho
Director
Period of report
Aug 25, 2015
Accepted (ET)
Aug 26, 2015 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF1 | Aug 25, 2015 | M | 16,615 | $1.09 | A | 156,672 | D | |
| Common stock, par value $0.001 per shareF1 | Aug 25, 2015 | F | 8,385 | — | D | 148,287 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $1.09 | Aug 25, 2015 | M | 25,000 | D | Nov 5, 2010 | Nov 5, 2015 | Common Stock | 25,000 | 125,000 | D |
Explanation of responses
- F1Holder exercised 25,000 options at $1.09 per share via cashless exercise and was issued 16,615 shares based on the August 25, 2015 closing price of $3.25 per share.